Aurevia Poland sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-07-25
Share capital
7,500.00 PLN
Activity description

Aurevia Poland is a consulting company that provides services in medtech regulatory compliance and clinical research, supporting pharmaceuticals, advanced therapy medicinal products (ATMPs), biologics, medical devices, and in vitro diagnostic (IVD) devices. They offer full-service clinical research organization (CRO) services and quality assurance and regulatory affairs services throughout the lifecycle of medical devices. Additionally, Aurevia Academy provides professional training in quality assurance, regulatory affairs, and clinical research.

Registered address
Dzwonkowa 104, 43-100 Tychy, Poland
Email
Social media
Electronic delivery address
AE:PL-76381-71631-EGWRR-21

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 147 days late).

  • 202522/06/2026
  • 202424/06/2025
  • 202325/06/2024
  • 2022filed
  • 202109/12/2022
  • 202022/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 13%
City · Tychy319 / 1,242
Top 26%
Voivodeship · Śląskie8,512 / 33,148
Top 26%
Country · Poland78,238 / 297,069
Top 26%

Results vs industry

Revenue
This companyUSD 1.33mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 171.08kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 1.05mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 1.33mMedianUSD 120.25kAverageUSD 3.90m

Offer

Certifications: ISO 13485

Websites

  • aurevia.comAurevia Quality, Regulatory and CRO Consulting Services
    HubSpotGoogle AnalyticsGoogle Tag ManagerCloudflare

Public procurement

1 tender recorded as contractor, with a total value of $292,558.

SubjectAmount
Sponsor support for conducting a non-commercial clinical trial (the so-called CRO service) under the project “Ocena skuteczności i bezpieczeństwa stosowania jodowych środków kontrastowych w mammografii spektralnej w korelacji z badaniem rezonansu magnetycznego piersi u chorych z podejrzeniem raka piersi.” for Uniwersytet Jagielloński – Collegium Medicum w Krakowie.
$292.6K

Job offers

The company lists 1 job opening on its own careers page: aurevia.com/careers.

Position
Clinical Research Associate (CRA)

Authorized Representatives

Tadeusz Baron age 53 – Management Board Member
Juha-Pekka Nuutinen age 52 – President of the Management Board

Manner of representation

The President of the Management Board independently; a member of the management board who is not the President of the Management Board jointly with another member of the management board or with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Aurevia Oy
150$2,025.93100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-01-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

12 public aid cases recorded, with a total value of $248,711.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$43,924
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$493
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$12,473

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Instytut Arcana sp. z o.o.
Pure Clinical sp. z o.o.
Aslab Science P.S.A.
Centrum Innowacji Grabowski sp. k.
TAK Pharma sp. z o.o.
Bioresearch Group sp. z o.o.
GJ Pharma sp. z o.o.
Pharmalogics sp. z o.o.
Centrum Hta sp. z o.o.
Globe Badania Kliniczne sp. z o.o.

Change history

DateEvent
2025-01-10Name change
2023-10-23PKD change
2021-01-21PKD change
2018-09-27Share capital increase
2015-08-01Business resumed

FAQ

Last updated: 2026-10-07